Results 251 to 260 of about 207,197 (306)

Development Strategies for Influenza Vaccines Utilizing Phage RNA Polymerase and Capping Enzyme NP868R. [PDF]

Chem Bio Eng
Wang W, Ma Z, Lou Q, Li T, Huang Z, Yin W, Lou C, Xiang Y.   +7 more
europepmc   +1 more source

Estimated Relative Effectiveness and Public Health Impact of Cell-Based Versus Egg-Based Influenza Vaccines During the 2022-2023 Season in the United States. [PDF]

Influenza Other Respir Viruses
Stein AN, Thanataveerat A, McDermott KW, Dean A, Wall S, Pack C, Sullivan SG, McGovern I, Haag MDM.   +8 more
europepmc   +1 more source

Global Health Implications of US Exit From WHO and Suspension of Aid

Public Health Challenges, Volume 5, Issue 2, June 2026.
Kenneth Chukwuebuka Egwu, Maryam Abdulkarim, Molly Unoh Ogbodum, Yusuff Adebayo Adebisi, Dukanwojo Beulah Suleman, Don Eliseo Lucero‐Prisno III   +5 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Influenza vaccines

Frontiers in Bioscience, 2008
Influenza viruses pose a major challenge to those concerned with global public health. Not only do influenza viruses cause yearly epidemics that are associated with slight changes in viral antigenicity, but occasionally new viruses cross from animal reservoirs into humans causing major pandemics.
Richard John, Webby, Matthew Robert, Sandbulte   +1 more
openaire   +2 more sources